Accordingly, HMGB1 knockout or pharmacological inhibition with glycyrrhizin impairs NHEJ and re-sensitizes resistant nasopharyngeal cancer cells to both ionizing radiation and cisplatin [37]. Here, HMGB1 is linked to nasopharyngeal carcinoma.